{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Gilead Sciences", "item": "https://www.patentleaderboard.com/2021/company/gilead-sciences"}, {"@type": "ListItem", "position": 4, "name": "Gregory Chin", "item": "https://www.patentleaderboard.com/2021/inventor/fl:gr_ln:chin-3"}]}

Home › 2021 › Gilead Sciences › Gregory Chin

Gregory Chin — 2 Patents in 2021

GSGilead Sciences: 2 patents #54 of 206Top 30%

San Francisco, CA: #1,355 of 7,035 inventorsTop 20%

California: #13,721 of 66,859 inventorsTop 25%

Overall (2021): #159,877 of 548,734Top 30%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11179397	Imidazopyrimidine derivatives	Michael O' Neil Hanrahan Clarke, Xiaochun Han, Tim Hansen, Yunfeng Eric Hu, Dmitry Koltun +6 more	2021-11-23	$216,502,000
11124487	Toll like receptor modulator compounds	Richard L. Mackman, Michael R. Mish, Jeff Zablocki	2021-09-21	$207,464,000

Gregory Chin — 2 Patents in 2021

Issued Patents 2021

Patent Widget